PHASE-1-2 CLINICAL-TRIAL SUPPORTS THE SAFETY AND EFFICACY OF TARGRETIN(TM) TOPICAL GEL, A NOVEL RXR-SELECTIVE RETINOID ANALOG, IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA

Authors
BRENEMAN DL DUVIC M KUZEL T STEVENS V YOCUM R
Citation
Dl. Breneman et al., PHASE-1-2 CLINICAL-TRIAL SUPPORTS THE SAFETY AND EFFICACY OF TARGRETIN(TM) TOPICAL GEL, A NOVEL RXR-SELECTIVE RETINOID ANALOG, IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA, Blood, 88(10), 1996, pp. 2265-2265
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
88
Issue
10
Year of publication
1996
Part
1
Supplement
1
Pages
2265 - 2265
Database
ISI
SICI code
0006-4971(1996)88:10<2265:PCSTSA>2.0.ZU;2-J